Previous studies also demonstrated that DR4 and DR5 receptors expressed in TRAIL-resistant bladder cancer cell lines at levels comparable to the TRAIL-sensitive ones [24], indicating that the TRAIL resistance of bladder cancer cells may depend more on the level of intracellular signaling molecules rather than differences in receptor expression. The gene discussed is TNFSF10; the disease is urinary bladder carcinoma.